echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 2019 pharmaceutical companies "top ten" typical tickets up to 83.17 million.

    2019 pharmaceutical companies "top ten" typical tickets up to 83.17 million.

    • Last Update: 2020-08-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In 2019, four of the most stringent, tax verification, environmental verification, health insurance negotiations, pharmaceutical bribery, Western drug consistency evaluation, chinese medicine prescription, Chinese medicine tablets pharmacopeia standards debate, etc. , the whole year is not calm.
    2019, institutional reform, the promulgation of the new drug law, the new version of the Pharmacopoeia 2020 will come again;
    2019, pharmaceutical companies are not easy, really not easy; In 2020, it's almost there! Everybody's holding on! The eventful autumn, the end of the year, some things, or worth counting;
    today we'll look at what the typical tickets have been for the past year.
    (Note: Not selected according to the fine, but based on the typical case.)
    ) Penalty one: keyword: anti-monopoly ticket 12.43 million yuan, see the monopoly of raw materials, henan enterprises and a Hunan enterprise two ponymion apiapi raw materials production enterprises, because of the suspected monopoly, was sentenced to 12.43 million yuan punishment.
    ticket two: keywords: tax verification ticket 83.17 million 77 pharmaceutical companies tax verification, the results published a lot;
    selected a representative: henan pharmaceutical company, for illegally obtaining 4501 VAT input invoices, the amount of 44,165.97 million, the amount of tax 7508.21 million, and other tax-related illegal issues, involving tax 809.72 million;
    Note: As of the date of the announcement, the administrative treatment is still unknown, and transferred to the judicial organs in accordance with the law.
    ticket three, keyword environmental protection ticket 1 million yuan a pharmaceutical company, because the masses report reflect the situation of waste water pumped to the sewer.
    investigation and verification, the pharmaceutical company is suspected of evading regulation will need to enter the wastewater treatment facilities to the treatment of wastewater entrusted to the company with outofing disposal capacity.
    this act violates the provisions of the Water Pollution Prevention and Control Law of the People's Republic of China, stipulated in 39, "artificial recharge of groundwater, and may not worsen groundwater quality."
    " was fined $1 million.
    ticket four, keywords unlicensed operation ticket 930,000 a pharmaceutical retail co., ltd., illegal purchase of Chinese medicine tablets a total of about 200 varieties of a total of 1536 batches.
    the parties to the business that go beyond the scope of business approved in the Drug Business License and engage in the retail operation of Chinese medicine tablets without authorization violate the "Drug operation enterprises shall operate drugs in accordance with the scope of business licensed under the Drug Business License" in accordance with Article 17, paragraph 2, of the Measures for the Supervision and Administration of Drug Circulation.
    " provisions.
    In view of the fact that the parties refused to cooperate with the investigation after the case, instigated others to provide perjury, and secretly continued to engage in illegal business practices and other circumstances, the Market Regulatory Bureau confiscated the parties seized Chinese medicine tablets;
    ticket five, keyword document rental ticket 510,000 A pharmaceutical company in the name of the enterprise for others to operate drugs to provide qualification documents and other facilities, rental "drug business license" and charge "management fees", rental time continued for more than 6 months, the number of drugs involved in the case is larger, the value of goods is larger.
    the drug supervision and administration department, the drug enterprise to take "heavy punishment", confiscation of illegal income at the same time, a fine of 388,280.46 yuan, a total fine, not 517707.28 yuan.
    ticket six, keywords illegal advertising ticket 700,000 yuan A pharmaceutical company through the live broadcast platform for live webcast.
    in the live broadcast by inviting male doctors, network red anchors, television hosts and so on as guests to participate, take the live arrangement of props, guests and host interaction, the prescription drug "Wan Ai Ke" efficacy, use methods, efficiency, etc. to introduce and promote, and in the verbal interaction appeared in the "provocative male, uniform temptation" and other content.
    at the same time, the parties in the live broadcast of the prescription drug "Wan Aike" second kill preferential sales activities.
    statistics, the live event online audience reached more than 150,000 people.
    Market Regulatory Authority pointed out that the parties using the webcast as a medium of communication to promote, promote and sell the prescription drug "Wan Aike" does not meet the definition of commercial advertising in Article 2 of the Advertising Law.
    the ad not only seriously violates prescription drug advertising regulations, but also contains other illegal content in the live broadcast that violates social good practices.
    , "Wan AiKe" (commonly known as sildenafil) is a prescription drug for men with erectile dysfunction that needs to be purchased and used on a physician's prescription.
    Article 15, paragraph 2, of the Advertising Law, prescription drugs may only be advertised in medical and pharmaceutical professional journals jointly designated by the administrative department of health under the State Council and the drug regulatory department under the State Council.
    in other words, even if the drug is to be advertised, can not be promoted on the Internet, let alone through live broadcast to promote.
    according to this, the Market Regulatory Bureau ordered the advertising publishers to stop publishing illegal advertising, a fine of 700,000 yuan administrative penalties.
    fine seven, keywords Bad drugs ticket 9.99 million a batch of drug produced by a pharmaceutical company "injection growth inhibitor" by the State Drug Administration issued a notice showed that its "content determination" project does not meet the standard requirements of the Chinese Pharmacopoeia.
    the pharmacopeia standard stipulates that the content should be "90.0-110.0% of the marked amount", but the batch of product content was found to exceed the upper limit (up to 111.8% and the lowest 110.6%), in violation of the relevant provisions of the Drug Administration Law of the People's Republic of China. Confiscation of the recalled batch of 1040 "injection growth inhibitors";
    the total amount of these two items is RMB 9,997,864.61.
    ticket eight, keywords bad drugs ticket 3.1 million yuan A pharmaceutical company yellow anti-venom tablets, tested by the Food and Drug Inspection Institute, the unqualified items for the "content determination", the test inglised on the basis of the 2015 edition of the Chinese Pharmacopoeia and the State Food and Drug Administration drug inspection supplementary inspection methods and inspection items approved 2008009 and 2008013.
    at the same time, the parties in the production, recall of the above-mentioned batch of oxaelin detox tablets in the process, there are still improper storage of intermediate prototheis tablets, improper handling of deviations and other violations of the "Drug Production Quality Management Code" and failure to timely notify the suspension of the sale and use of the need to recall the cattle yellow detox tablets.
    and given the following administrative penalties: 1, warning; 2, confiscation of 170601 batch of cattle yellow detox tablets 4860 bottles (value of 76253.4 yuan); 3, confiscation of illegal income 723983.67 yuan; 4, fine RMB 2436218.4.
    ticket nine, keywords bad medicine ticket 730,000 yuan A Chinese medicine drink tablet production and a pharmaceutical company sales of Chaihu, after testing, the results do not meet the "China Pharmacopoeia" 2015 edition of a relevant standard provisions.
    received the non-conformity inspection report, Chinese medicine tablet selling enterprises colluded with pharmaceutical companies to jointly forge a set of the batch of Chinese medicine drink tablets Chaihu production, inspection, sales records, the production and sales volume from the original 949.88 kg fabricated into 49.88 kg, after law enforcement personnel to carry out peripheral verification found.
    in view of the above illegal facts, the Drug Administration made the following treatment: 1, the Chinese medicine drink tablets production enterprises to confiscate the legal recall of inferior chinese medicine drink tablets Chaihu 2.35 kg and the sale of inferior Chinese medicine drink tablets Chaihu illegal income of 836,000 yuan, and the illegal production of inferior Chinese medicine drink tablets Chaihu value of 3 times the fine of 2515 million yuan, a total fine of 33.51 million yuan.
    2, the pharmaceutical company to confiscate the sale of inferior Chinese medicine drink tablets Chaihu illegal income of 991 million yuan, and illegal sales of inferior Chinese medicine drink tablets Chaihu value of 3 times the amount of a fine of 2982 million yuan, a total of 3974 million yuan.
    fine ten, fine number of 16 tickets up to 66,000 tickets a drink tablet production enterprise production of 2 batches of Chinese medicine tablets and 1 batch of jaundice, after testing, the results are not in accordance with the provisions, are in accordance with the inferior drug theory, and the parties have not in accordance with the statutory standards of the purchase of the real, jaundice medicine and other acts.
    In accordance with the relevant provisions of the Drug Administration Law of the People's Republic of China, the Regulations on the Implementation of the Drug Administration Law of the People's Republic of China, and the Discretion of Drug Administrative Penalties of the Food and Drug Administration of a Province, the Provincial Market Supervision Administration issued a penalty decision on March 29, 2019, confiscating the illegal proceeds of recalled and selling inferior drugs of 11361.3 yuan, and imposing a fine of 54,785.9 yuan, and imposing a total fine of 66147.2 yuan;
    another inquiry, the enterprise has been punished 16 times.
    (Note: the amount of the enterprise fine is small, but more times; of course, in the peer, absolutely not because of non-conformity was punished the most times, only choose a representative bar) extra-commissioned ticket: keywords the court does not support the ticket 40 million a pharmaceutical equipment company, in the case of not obtaining the sterile registration certificate (Note: the old certificate has expired), unauthorized production of 25 sterilizers and sold to the relevant institutions;
    , the equipment company to a hospital when the sale of sterilization devices to provide medical device registration, confirmed to be forged.
    shall be fined 1, and the illegal proceeds shall be confiscated by 4120 yuan; 2, and a fine of 20615200 yuan; and 3, and a fine of 20615200.
    the total amount of the penalty amounted to 41234520 yuan.
    but the decision on the penalty in the case was rejected by the local court, and the request was lenient.
    is a bit representative, although it happened in 2018, only recently to pay attention to, also put here.
    the end of 2018, there have been several incidents, but also a brief review: a foreign investment for bribery of non-state workers, fines of 3 billion;
    mo api three enterprises, a fine of 12.83 million.
    because the information is source network, if the key information is inaccurate, please promptly feedback correction.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.